The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lancing Devices for Self-Monitoring of Blood Glucose Market Research Report 2025
Synopsis
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The global Lancing Devices for Self-Monitoring of Blood Glucose market was valued at US$ 215.6 million in 2023 and is anticipated to reach US$ 307.4 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The Lancing Devices market is driven by the increasing prevalence of diabetes and the need for efficient blood glucose monitoring. Lancing devices are essential tools for obtaining blood samples for glucose testing. The rise in diabetes cases and the emphasis on self-management contribute to market growth as individuals seek user-friendly and less painful testing solutions. Moreover, advancements in lancing device technology, including adjustable depth and less invasive mechanisms, align with patient preferences. However, the market also faces challenges, including addressing the discomfort associated with frequent testing and ensuring consistent blood sample quality. Additionally, promoting proper lancing technique and minimizing infection risks can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and comfortable lancing devices, collaborate with healthcare professionals for patient education, and address the challenges to meet the increasing demand for accurate and patient-friendly blood glucose monitoring solutions.
This report aims to provide a comprehensive presentation of the global market for Lancing Devices for Self-Monitoring of Blood Glucose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lancing Devices for Self-Monitoring of Blood Glucose.
Report Scope
The Lancing Devices for Self-Monitoring of Blood Glucose market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lancing Devices for Self-Monitoring of Blood Glucose market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lancing Devices for Self-Monitoring of Blood Glucose manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Online
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lancing Devices for Self-Monitoring of Blood Glucose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lancing Devices for Self-Monitoring of Blood Glucose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The global Lancing Devices for Self-Monitoring of Blood Glucose market was valued at US$ 215.6 million in 2023 and is anticipated to reach US$ 307.4 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The Lancing Devices market is driven by the increasing prevalence of diabetes and the need for efficient blood glucose monitoring. Lancing devices are essential tools for obtaining blood samples for glucose testing. The rise in diabetes cases and the emphasis on self-management contribute to market growth as individuals seek user-friendly and less painful testing solutions. Moreover, advancements in lancing device technology, including adjustable depth and less invasive mechanisms, align with patient preferences. However, the market also faces challenges, including addressing the discomfort associated with frequent testing and ensuring consistent blood sample quality. Additionally, promoting proper lancing technique and minimizing infection risks can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and comfortable lancing devices, collaborate with healthcare professionals for patient education, and address the challenges to meet the increasing demand for accurate and patient-friendly blood glucose monitoring solutions.
This report aims to provide a comprehensive presentation of the global market for Lancing Devices for Self-Monitoring of Blood Glucose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lancing Devices for Self-Monitoring of Blood Glucose.
Report Scope
The Lancing Devices for Self-Monitoring of Blood Glucose market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lancing Devices for Self-Monitoring of Blood Glucose market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lancing Devices for Self-Monitoring of Blood Glucose manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Segment by Application
Online
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lancing Devices for Self-Monitoring of Blood Glucose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lancing Devices for Self-Monitoring of Blood Glucose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lancing Devices for Self-Monitoring of Blood Glucose Market Overview
1.1 Product Overview and Scope of Lancing Devices for Self-Monitoring of Blood Glucose
1.2 Lancing Devices for Self-Monitoring of Blood Glucose Segment by Type
1.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value Comparison by Type (2024-2030)
1.2.2 Adjustable Lancing Device
1.2.3 Non-adjustable Lancing Device
1.3 Lancing Devices for Self-Monitoring of Blood Glucose Segment by Application
1.3.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value by Application: (2024-2030)
1.3.2 Online
1.3.3 Offline
1.4 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size Estimates and Forecasts
1.4.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue 2019-2030
1.4.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales 2019-2030
1.4.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lancing Devices for Self-Monitoring of Blood Glucose Market Competition by Manufacturers
2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Average Price by Manufacturers (2019-2024)
2.4 Global Lancing Devices for Self-Monitoring of Blood Glucose Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose, Product Type & Application
2.7 Lancing Devices for Self-Monitoring of Blood Glucose Market Competitive Situation and Trends
2.7.1 Lancing Devices for Self-Monitoring of Blood Glucose Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lancing Devices for Self-Monitoring of Blood Glucose Players Market Share by Revenue
2.7.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lancing Devices for Self-Monitoring of Blood Glucose Retrospective Market Scenario by Region
3.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region: 2019-2030
3.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region: 2019-2024
3.2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region: 2025-2030
3.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region: 2019-2030
3.3.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region: 2019-2024
3.3.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region: 2025-2030
3.4 North America Lancing Devices for Self-Monitoring of Blood Glucose Market Facts & Figures by Country
3.4.1 North America Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2030)
3.4.3 North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lancing Devices for Self-Monitoring of Blood Glucose Market Facts & Figures by Country
3.5.1 Europe Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2030)
3.5.3 Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Market Facts & Figures by Country
3.6.1 Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2030)
3.6.3 Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lancing Devices for Self-Monitoring of Blood Glucose Market Facts & Figures by Country
3.7.1 Latin America Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2030)
3.7.3 Latin America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lancing Devices for Self-Monitoring of Blood Glucose Market Facts & Figures by Country
3.8.1 Middle East and Africa Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type (2019-2030)
4.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type (2019-2024)
4.1.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Type (2025-2030)
4.1.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Type (2019-2030)
4.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Type (2019-2030)
4.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Type (2019-2024)
4.2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Type (2025-2030)
4.2.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Type (2019-2030)
4.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application (2019-2030)
5.1.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application (2019-2024)
5.1.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Application (2025-2030)
5.1.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Application (2019-2030)
5.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Application (2019-2030)
5.2.1 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Application (2019-2024)
5.2.2 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Application (2025-2030)
5.2.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Application (2019-2030)
5.3 Global Lancing Devices for Self-Monitoring of Blood Glucose Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Corporation Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 TERUMO
6.6.1 TERUMO Corporation Information
6.6.2 TERUMO Description and Business Overview
6.6.3 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.6.5 TERUMO Recent Developments/Updates
6.7 Sinocare
6.6.1 Sinocare Corporation Information
6.6.2 Sinocare Description and Business Overview
6.6.3 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.7.5 Sinocare Recent Developments/Updates
6.8 ARKRAY
6.8.1 ARKRAY Corporation Information
6.8.2 ARKRAY Description and Business Overview
6.8.3 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.8.5 ARKRAY Recent Developments/Updates
6.9 GMMC Group
6.9.1 GMMC Group Corporation Information
6.9.2 GMMC Group Description and Business Overview
6.9.3 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.9.5 GMMC Group Recent Developments/Updates
6.10 BIONIME
6.10.1 BIONIME Corporation Information
6.10.2 BIONIME Description and Business Overview
6.10.3 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.10.5 BIONIME Recent Developments/Updates
6.11 LIANFA
6.11.1 LIANFA Corporation Information
6.11.2 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Description and Business Overview
6.11.3 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.11.5 LIANFA Recent Developments/Updates
6.12 Lobeck Medical AG
6.12.1 Lobeck Medical AG Corporation Information
6.12.2 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Description and Business Overview
6.12.3 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Product Portfolio
6.12.5 Lobeck Medical AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lancing Devices for Self-Monitoring of Blood Glucose Industry Chain Analysis
7.2 Lancing Devices for Self-Monitoring of Blood Glucose Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lancing Devices for Self-Monitoring of Blood Glucose Production Mode & Process
7.4 Lancing Devices for Self-Monitoring of Blood Glucose Sales and Marketing
7.4.1 Lancing Devices for Self-Monitoring of Blood Glucose Sales Channels
7.4.2 Lancing Devices for Self-Monitoring of Blood Glucose Distributors
7.5 Lancing Devices for Self-Monitoring of Blood Glucose Customers
8 Lancing Devices for Self-Monitoring of Blood Glucose Market Dynamics
8.1 Lancing Devices for Self-Monitoring of Blood Glucose Industry Trends
8.2 Lancing Devices for Self-Monitoring of Blood Glucose Market Drivers
8.3 Lancing Devices for Self-Monitoring of Blood Glucose Market Challenges
8.4 Lancing Devices for Self-Monitoring of Blood Glucose Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lancing Devices for Self-Monitoring of Blood Glucose Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lancing Devices for Self-Monitoring of Blood Glucose, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose, Product Type & Application
Table 12. Global Key Manufacturers of Lancing Devices for Self-Monitoring of Blood Glucose, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lancing Devices for Self-Monitoring of Blood Glucose by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lancing Devices for Self-Monitoring of Blood Glucose as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region (2019-2024) & (K Units)
Table 18. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Region (2019-2024)
Table 19. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region (2025-2030) & (K Units)
Table 20. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Region (2025-2030)
Table 21. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Region (2019-2024)
Table 23. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Region (2025-2030)
Table 25. North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2024) & (K Units)
Table 27. North America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2025-2030) & (K Units)
Table 28. North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2024) & (K Units)
Table 32. Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2025-2030) & (K Units)
Table 33. Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units) by Type (2019-2024)
Table 51. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units) by Type (2025-2030)
Table 52. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Type (2019-2024)
Table 53. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Type (2025-2030)
Table 54. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Type (2019-2024)
Table 57. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Type (2025-2030)
Table 58. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Type (2019-2024)
Table 59. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Type (2025-2030)
Table 60. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units) by Application (2019-2024)
Table 61. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units) by Application (2025-2030)
Table 62. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Application (2019-2024)
Table 63. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Application (2025-2030)
Table 64. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Application (2019-2024)
Table 67. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Application (2025-2030)
Table 68. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Application (2019-2024)
Table 69. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 74. Roche Recent Developments/Updates
Table 75. Lifescan Corporation Information
Table 76. Lifescan Description and Business Overview
Table 77. Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Lifescan Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 79. Lifescan Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 84. Abbott Recent Developments/Updates
Table 85. Ascensia Corporation Information
Table 86. Ascensia Description and Business Overview
Table 87. Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ascensia Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 89. Ascensia Recent Developments/Updates
Table 90. B. Braun Corporation Information
Table 91. B. Braun Description and Business Overview
Table 92. B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. B. Braun Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 94. B. Braun Recent Developments/Updates
Table 95. TERUMO Corporation Information
Table 96. TERUMO Description and Business Overview
Table 97. TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. TERUMO Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 99. TERUMO Recent Developments/Updates
Table 100. Sinocare Corporation Information
Table 101. Sinocare Description and Business Overview
Table 102. Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sinocare Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 104. Sinocare Recent Developments/Updates
Table 105. ARKRAY Corporation Information
Table 106. ARKRAY Description and Business Overview
Table 107. ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. ARKRAY Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 109. ARKRAY Recent Developments/Updates
Table 110. GMMC Group Corporation Information
Table 111. GMMC Group Description and Business Overview
Table 112. GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. GMMC Group Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 114. GMMC Group Recent Developments/Updates
Table 115. BIONIME Corporation Information
Table 116. BIONIME Description and Business Overview
Table 117. BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. BIONIME Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 119. BIONIME Recent Developments/Updates
Table 120. LIANFA Corporation Information
Table 121. LIANFA Description and Business Overview
Table 122. LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. LIANFA Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 124. LIANFA Recent Developments/Updates
Table 125. Lobeck Medical AG Corporation Information
Table 126. Lobeck Medical AG Description and Business Overview
Table 127. Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Lobeck Medical AG Lancing Devices for Self-Monitoring of Blood Glucose Product
Table 129. Lobeck Medical AG Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Lancing Devices for Self-Monitoring of Blood Glucose Distributors List
Table 133. Lancing Devices for Self-Monitoring of Blood Glucose Customers List
Table 134. Lancing Devices for Self-Monitoring of Blood Glucose Market Trends
Table 135. Lancing Devices for Self-Monitoring of Blood Glucose Market Drivers
Table 136. Lancing Devices for Self-Monitoring of Blood Glucose Market Challenges
Table 137. Lancing Devices for Self-Monitoring of Blood Glucose Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lancing Devices for Self-Monitoring of Blood Glucose
Figure 2. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Share by Type in 2023 & 2030
Figure 4. Adjustable Lancing Device Product Picture
Figure 5. Non-adjustable Lancing Device Product Picture
Figure 6. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Share by Application in 2023 & 2030
Figure 8. Online
Figure 9. Offline
Figure 10. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size (2019-2030) & (US$ Million)
Figure 12. Global Lancing Devices for Self-Monitoring of Blood Glucose Sales (2019-2030) & (K Units)
Figure 13. Global Lancing Devices for Self-Monitoring of Blood Glucose Average Price (US$/Unit) & (2019-2030)
Figure 14. Lancing Devices for Self-Monitoring of Blood Glucose Report Years Considered
Figure 15. Lancing Devices for Self-Monitoring of Blood Glucose Sales Share by Manufacturers in 2023
Figure 16. Global Lancing Devices for Self-Monitoring of Blood Glucose Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Lancing Devices for Self-Monitoring of Blood Glucose Players: Market Share by Revenue in 2023
Figure 18. Lancing Devices for Self-Monitoring of Blood Glucose Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Lancing Devices for Self-Monitoring of Blood Glucose Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Country (2019-2030)
Figure 21. North America Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Country (2019-2030)
Figure 22. United States Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Country (2019-2030)
Figure 25. Europe Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Country (2019-2030)
Figure 26. Germany Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Region (2019-2030)
Figure 33. China Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Country (2019-2030)
Figure 43. Latin America Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Lancing Devices for Self-Monitoring of Blood Glucose Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Lancing Devices for Self-Monitoring of Blood Glucose Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Lancing Devices for Self-Monitoring of Blood Glucose by Type (2019-2030)
Figure 53. Global Revenue Market Share of Lancing Devices for Self-Monitoring of Blood Glucose by Type (2019-2030)
Figure 54. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Lancing Devices for Self-Monitoring of Blood Glucose by Application (2019-2030)
Figure 56. Global Revenue Market Share of Lancing Devices for Self-Monitoring of Blood Glucose by Application (2019-2030)
Figure 57. Global Lancing Devices for Self-Monitoring of Blood Glucose Price (US$/Unit) by Application (2019-2030)
Figure 58. Lancing Devices for Self-Monitoring of Blood Glucose Value Chain
Figure 59. Lancing Devices for Self-Monitoring of Blood Glucose Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
